Epidemiological evidence concerning the association between onchocerciasis and epilepsy

Affiliations

¹ Global Health Institute, University of Antwerp, Antwerp, Belgium.
² Ministry of Health, Bas-Uélé, Congo.
³ Global Health Institute, University of Antwerp, Antwerp, Belgium. Electronic address: robert.colebunders@uantwerpen.be.

Free article

Comment

J N Siewe Fodjo et al. Int J Infect Dis. 2019 May.

Free article

. 2019 May:82:77-78.

doi: 10.1016/j.ijid.2019.03.015. Epub 2019 Mar 15.

¹ Global Health Institute, University of Antwerp, Antwerp, Belgium.
² Ministry of Health, Bas-Uélé, Congo.
³ Global Health Institute, University of Antwerp, Antwerp, Belgium. Electronic address: robert.colebunders@uantwerpen.be.

No abstract available

Comment on

Onchocerciasis associated epilepsy-A question of causality.
Cantey PT, Sejvar J. Cantey PT, et al. Int J Infect Dis. 2019 Feb;79:185-186. doi: 10.1016/j.ijid.2019.01.044. Int J Infect Dis. 2019. PMID: 30711144 Free PMC article. No abstract available.
High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.
Mukendi D, Tepage F, Akonda I, Siewe JNF, Rotsaert A, Ndibmun CN, Laudisoit A, Couvreur S, Kabutako B, Menon S, Hotterbeekx A, Colebunders R. Mukendi D, et al. Int J Infect Dis. 2019 Feb;79:187-194. doi: 10.1016/j.ijid.2018.10.021. Int J Infect Dis. 2019. PMID: 30711145 Free PMC article.